These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 16521890)

  • 1. How MFN clauses used in the health care industry unreasonably restrain trade under the Sherman Act.
    Wright BA
    J Law Health; 2003-2004; 18(1):29-55. PubMed ID: 16521890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A competitive analysis of most favored nations clauses in contracts between health care providers and insurers.
    Celnicker A
    Spec Law Dig Health Care (Mon); 1991 Dec; (154):7-36. PubMed ID: 10115476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unbridled managed care: when consumers experience antitrust welfare loss from exclusionary contracts between HMO insurers and health care providers.
    Ruskin A
    Health Matrix Clevel; 1996; 6(2):391-469. PubMed ID: 10178393
    [No Abstract]   [Full Text] [Related]  

  • 4. Do State Bans of Most-Favored-Nation Contract Clauses Restrain Price Growth? Evidence From Hospital Prices.
    Arnold DR; Gudiksen KL; King JS; Fulton BD; Scheffler RM
    Milbank Q; 2022 Jun; 100(2):589-615. PubMed ID: 35537077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The stifling of competition by the antitrust laws: the irony of the health care industry.
    Powers JA
    J Law Health; 2000-2001; 15(2):223-46. PubMed ID: 12238323
    [No Abstract]   [Full Text] [Related]  

  • 6. Medical care. Antitrust laws emerging exemption.
    Troupis JR
    Benders Health Care Law Mon; 1997 Jul; ():3-10. PubMed ID: 10173326
    [No Abstract]   [Full Text] [Related]  

  • 7. Antitrust principles for radiologists.
    Reuter SR
    AJR Am J Roentgenol; 1990 Dec; 155(6):1331-7. PubMed ID: 2122690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preferred provider organizations: antitrust aspects and implications for the hospital industry.
    Batavia AI
    Am J Law Med; 1984; 10(2):169-88. PubMed ID: 6528879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Most-favored-nation clauses and monopsonistic power: an unhealthy mix?
    Stenger SE
    Am J Law Med; 1989; 15(1):111-28. PubMed ID: 2764011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "No-hire" clauses in healthcare sector contracts: their use and enforceability.
    Basanta WE
    J Health Law; 2006; 39(4):451-95. PubMed ID: 17402657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HMO consolidation: a threat to network integration?
    Med Netw Strategy Rep; 1999 Nov; 8(11):1-7. PubMed ID: 10724558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can HMOs wield market power? Assessing antitrust liability in the imperfect market for health care financing.
    Glassman ML
    Am Univ Law Rev; 1996 Oct; 46(1):91-147. PubMed ID: 10169685
    [No Abstract]   [Full Text] [Related]  

  • 13. Monopoly, monopsony, and market definition: an antitrust perspective on market concentration among health insurers.
    Hyman DA; Kovacic WE
    Health Aff (Millwood); 2004; 23(6):25-8. PubMed ID: 15537581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perspectives. Regulation in the market: friend or foe of competition?
    Cunningham R
    Med Health; 1998 Mar; 52(11):suppl 1-4. PubMed ID: 10176905
    [No Abstract]   [Full Text] [Related]  

  • 15. Regulating managed care plans: is the telecommunications industry a possible model?
    Jorgensen NE; Weil TP
    Manag Care Q; 1998; 6(3):7-16. PubMed ID: 10182534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Department of Justice challenging big insurers' "Most Favored Nation" clauses.
    Stepovich M
    Health Care Law Newsl; 1995 Sep; 10(9):3-4. PubMed ID: 10144889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Managed care and the infamous hold harmless clause.
    Overlock ME
    J Tenn Med Assoc; 1993 Oct; 86(10):453-6. PubMed ID: 8231185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitrust and health care: provider controlled health plans and the Maricopa decision.
    Weller CD
    Am J Law Med; 1982; 8(3):223-49. PubMed ID: 6897759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Applying antitrust law to nonprofit healthcare entities: arguments for a greater attention to detail.
    Swearingen MJ
    J Health Law; 2000; 33(1):57-101. PubMed ID: 10788231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physician gag clauses--the hypocrisy of the Hippocratic Oath.
    Swanson DS
    South Ill Univ Law J; 1997; 21():313-34. PubMed ID: 16086489
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.